Ovid Therapeutics (OVID) EPS (Basic) (2016 - 2026)
Ovid Therapeutics' (OVID) quarterly EPS (Basic) came in at -$0.08 in Q2 2026, down 15.4% on a YoY basis from -$0.09 in Q2 2025, and up 39.07% quarter-over-quarter from -$0.12 in Q1 2026.
Powered by 
Analysis
Ovid Therapeutics (OVID) EPS (Basic) (2016 - 2026) Analysis & Trends
Ovid Therapeutics (OVID) has reported EPS (Basic) for 11 consecutive years, with -$0.08 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, EPS (Basic) fell 15.4% year-over-year to -$0.08; the trailing twelve-month figure through Jun 2026 stood at -$0.17 (up 67.46% YoY), and the FY2025 full-year result was -$0.24, up 36.65% from the prior year.
- EPS (Basic) advanced to -$0.08 in Q2 2026 per OVID's latest filing, from -$0.12 in the prior quarter.
- Across five years, EPS (Basic) topped out at $0.13 in Q4 2025 and bottomed at -$0.23 in Q1 2022.
- Historically, EPS (Basic) has averaged -$0.13 across 5 years, with a median of -$0.16 in 2022.
- The widest YoY moves for EPS (Basic): up 200.42% in 2025, down 154.82% in 2025.
- Over 5 years, EPS (Basic) stood at -$0.16 in 2022, then tumbled by 32.88% to -$0.22 in 2023, then jumped by 39.89% to -$0.13 in 2024, then jumped by 200.42% to $0.13 in 2025, then tumbled by 158.0% to -$0.08 in 2026.
- According to Business Quant data, EPS (Basic) over the past three periods registered -$0.08, -$0.12, and $0.13 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 663.08 Bn | 642.33 Bn | 17.26 Bn | 2.30 |
| 2 | AbbVie | 453.04 Bn | 446.51 Bn | 12.70 Bn | 2.04 |
| 3 | Merck | 370.87 Bn | 363.78 Bn | 12.21 Bn | -0.54 |
| 4 | Novartis Ag | 305.29 Bn | 298.00 Bn | 11.24 Bn | 1.68 |
| 5 | Pfizer | 162.10 Bn | 150.70 Bn | 10.94 Bn | -0.04 |
| 6 | Sanofi | 53.95 Bn | 46.98 Bn | 10.79 Bn | 0.33 |
| 7 | Revolution Medicines | 45.00 Bn | 45.00 Bn | - | -3.06 |
| 8 | BeOne Medicines | 40.49 Bn | 35.39 Bn | 1.53 Bn | 2.12 |
| 9 | Incyte | 25.47 Bn | 20.94 Bn | 1.57 Bn | 2.92 |
| 10 | Ovid Therapeutics | 517.32 Mn | 400.10 Mn | - | -0.08 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -0.08 |
| Mar 31, 2026 | -0.12 |
| Dec 31, 2025 | 0.13 |
| Sep 30, 2025 | -0.17 |
| Jun 30, 2025 | -0.07 |
| Mar 31, 2025 | -0.14 |
| Dec 31, 2024 | -0.13 |
| Sep 30, 2024 | -0.20 |
| Jun 30, 2024 | 0.12 |
| Mar 31, 2024 | -0.17 |
| Dec 31, 2023 | -0.22 |
| Sep 30, 2023 | -0.16 |
| Jun 30, 2023 | -0.18 |
| Mar 31, 2023 | -0.19 |
| Dec 31, 2022 | -0.16 |
| Sep 30, 2022 | -0.17 |
| Jun 30, 2022 | -0.21 |
| Mar 31, 2022 | -0.23 |
| Dec 31, 2021 | -0.39 |
| Sep 30, 2021 | -0.17 |